These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16805251)

  • 1. [Good evidence for benefits of cholinesterase inhibitors in Parkinson dementia is still missing].
    Larsson A
    Lakartidningen; 2006 May 10-16; 103(19):1537; discussion 1537-8. PubMed ID: 16805251
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dementia--common, difficult to treat complication in Parkinson disease. Early diagnosis valuable--cholinesterase inhibitors can give better quality of life].
    Lökk J; Winblad B
    Lakartidningen; 2006 Feb 15-21; 103(7):451-5. PubMed ID: 16535872
    [No Abstract]   [Full Text] [Related]  

  • 3. [Rivastigmine against dementia in Parkinson disease?].
    Landmark K; Reikvam A
    Tidsskr Nor Laegeforen; 2007 Nov; 127(22):2973; author reply 2973-4. PubMed ID: 18026256
    [No Abstract]   [Full Text] [Related]  

  • 4. Parkinson's disease dementia--a first step?
    Press DZ
    N Engl J Med; 2004 Dec; 351(24):2547-9. PubMed ID: 15590960
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of degenerative dementia disorders--who should be treated?].
    Hasselbalch SG; Kampmann JP
    Ugeskr Laeger; 2009 Mar; 171(10):802-5. PubMed ID: 19265606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of dementia associated with Parkinson's disease.
    Emre M
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S457-61. PubMed ID: 18267283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for cholinesterase-inhibitor therapy for dementia associated with Parkinson's disease.
    Boeve BF
    Lancet Neurol; 2005 Mar; 4(3):137-8. PubMed ID: 15721821
    [No Abstract]   [Full Text] [Related]  

  • 8. A review of studies describing the use of acetyl cholinesterase inhibitors in Parkinson's disease dementia.
    Maidment ID; Fox C; Boustani M
    Acta Psychiatr Scand; 2005 Jun; 111(6):403-9. PubMed ID: 15877706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy of Parkinson disease dementia and Lewy body dementia.
    Gauthier S
    Front Neurol Neurosci; 2009; 24():135-139. PubMed ID: 19182471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rivastigmine: new indication. Dementia and Parkinson's disease: no thank you!
    Prescrire Int; 2007 Apr; 16(88):66. PubMed ID: 17458048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dementia in Parkinson's disease].
    Halvorsen Ø; Tysnes OB
    Tidsskr Nor Laegeforen; 2007 Oct; 127(19):2517-20. PubMed ID: 17925819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinesterase inhibitors: tremor and exacerbation of Parkinson's disease.
    Prescrire Int; 2007 Oct; 16(91):197-8. PubMed ID: 17926835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment options for non-motor symptoms in late-stage Parkinson's disease.
    Coelho M; Ferreira J; Rosa M; Sampaio C
    Expert Opin Pharmacother; 2008 Mar; 9(4):523-35. PubMed ID: 18312155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A reply to Pfizer: Still no reason to change SBU's conclusions on drugs against dementia].
    Edhag O; Norlund A
    Lakartidningen; 2007 Jan 10-16; 104(1-2):55. PubMed ID: 17323745
    [No Abstract]   [Full Text] [Related]  

  • 15. Cholinesterase inhibition in Parkinson's disease.
    Hutchinson M; Fazzini E
    J Neurol Neurosurg Psychiatry; 1996 Sep; 61(3):324-5. PubMed ID: 8795611
    [No Abstract]   [Full Text] [Related]  

  • 16. Cognitive disturbances in Parkinson's disease.
    Grujic Z
    Dis Mon; 2007 May; 53(5):302-8. PubMed ID: 17656192
    [No Abstract]   [Full Text] [Related]  

  • 17. Reports in pharmacological treatments in geriatric psychiatry: is there anything new or just adding to old evidence?
    Laks J; Engelhardt E
    Curr Opin Psychiatry; 2008 Nov; 21(6):562-7. PubMed ID: 18852563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rivastigmine for dementia associated with Parkinson's disease.
    Harada CN; Shega JW; Sachs GA
    N Engl J Med; 2005 Mar; 352(13):1387; author reply 1387. PubMed ID: 15800242
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of dementia: anything new?
    Machado JC; Caramelli P
    Curr Opin Psychiatry; 2006 Nov; 19(6):575-80. PubMed ID: 17012934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rivastigmine in Parkinson's disease dementia.
    Lalli S; Albanese A
    Expert Rev Neurother; 2008 Aug; 8(8):1181-8. PubMed ID: 18671661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.